Pinned Tweet
Excited to share a publication from my PhD work in Nature Communications. Grateful to Dr. Frederic Bost for his mentorship and to the Ligue contre le cancer for supporting this research.
#NatureCommunications #ProstateCancer #c3m nature.com/articles/s41467-0…
Michel Kahi retweeted
Too many researchers and evaluation committees remain obsessed with Journal IF but reputation among peers matters too!
JUFO, a Finnish initiative evaluating journals through expert panels, offers an interesting alternative. Worth exploring!
jfp.csc.fi/jufoportal
Michel Kahi retweeted
Ever wondered what happens #Metabolically throughout the body when the presence of #Cancer results in life-threatening debilitating loss of #Muscle and #Fat in patients, decreasing their quality of life, and preventing them from receiving therapy they need to extend #Survival?
Michel Kahi retweeted
Mitophagy is everywhere in cancer reviews but rarely studied in vivo. We tracked it during lung tumor development and show that PINK1-dependent mitophagy is activated early during transformation and is a targetable vulnerability in KRAS lung cancer.
science.org/doi/10.1126/scia…
Michel Kahi retweeted
Today I smiled for real for the first time in more than 5 years. Thank you to the jury, judge, court officer and clerk. And of course to my rockstar legal team. I truly wish the best for everyone involved.
A civil jury ruled in favor of ex-MIT scientist David Sabatini, who was accused by a younger colleague of inappropriate sexual conduct in his Cambridge research lab, and awarded him $6 million in damages. trib.al/s3v9VIX
Michel Kahi retweeted
Out today in Immunity! Our pan-atlas of human immune aging: 12.4 million PBMCs from 2,609 people across 8 global cohorts (including new 188 people cohort from UK).
cell.com/immunity/fulltext/S…
We map shared aging patterns onto 59 key immune populations and link the balance of GZMK+ and GZMB+ CD8 effector memory T cells to health trajectories; show differences in RTEs and Th2s with sex etc; ethnicity associated features.
artyomovlab.wustl.edu/human-…
How it came to be:
in 2023 we published first hierarchically annotatied atlas of human immune aging in PBMC - 166 people, 55 populations, key changes revealed - CD8 naives, KLRC2/NKG2C+ CD8 memory going down, GZMK+ CD8 T cells and Th2 and Tc2 type 2 memory cells going up! (Terekhova et al, Immunity 2023)
in 2024 we added major phenotypes within naive cells - SOX4+ RTE cells and their CD38 marker going down. (Bohacova et al, Immunity 2024)
In 2025-26 more atlases published with their own annotations making impossible to leverage power of data..
Now we provide unique in its power and consistency resource - 2600 people across ages, sexes, races, continents etc. All annotated in sync and analyzed for what aging looks like globally!
Ever wonder if tRNAs can regulate the identity of a cancer cell?
@HsiehLab @FredHutch postdoc @yeonsookim_phd did and discovered a single tRNA that can control lineage dependency and drug sensitivity in prostate cancer published today @Nature: nature.com/articles/s41586-0…
Michel Kahi retweeted
We are hiring!
Looking for a highly motivated postdoc with expertise in cancer metabolism to join our team in Nice 🇫🇷.
Exciting project exploring metabolic vulnerabilities and therapy resistance in cancer.
Please spread the word!
jobleads.com/fr/job/post-doc…
Michel Kahi retweeted
Beyond gene transcription, #Glucocorticoids regulate mRNA translation by remodeling P-bodies, revealing a sequence-dependent mechanism that reshapes protein production and #CellularStress adaptation.
#STTT #OpenAccess: doi.org/10.1038/s41392-026-0…
Michel Kahi retweeted
Congratulations to Dr. Matthew Vander Heiden, director of the @KochInstitute, on his appointment as @CD_AACR editor-in-chief.His leadership will advance the field of cancer research.
Read more in the #AACIUpdate: aaci-cancer.org/aaci-update-… #Awards #Honors
Michel Kahi retweeted
Excited to share our latest study with @camille_lobry! Using multiple AML models, we identified splicing dysregulation as a key feature of chemoresistance and relapse in AML. @Institut_IRSL @Leukemia_Inst @ScienceTM
tinyurl.com/mt932jky
Thrilled to share the publication of our latest piece of research in @ScienceTM, in collaboration with and led by the amazing @LabPuissantand Camille Vaganay Why does acute myeloid leukemia (AML) so often relapse after chemo works at first?
tinyurl.com/mt932jky
🧵
Michel Kahi retweeted
Great presentation by Michel Kahi at the 13th annual seminar of the Canceropole PACA @Michelkahi @laliguecancer
Michel Kahi retweeted
A recent study in Nature Communications reveals over 250 metabolic enzymes located directly on chromatin, a discovery that vastly expands the previously known count of only about 20.
nature.com/articles/s41467-0…
Michel Kahi retweeted
Our story on #FBXW7 and #biotin in #glutamine_addiction is now peer-reviewed and published in @MolecularCell! Heroic work led by the very first postdoc of the lab @miriamlisci. Have a look!
cell.com/molecular-cell/full…
Michel Kahi retweeted
ROhm Feb 24
RESEARCH | @MorignyPauline @ondrej_kuda @RohmMaria (@HelmholtzMunich )
Multi-omics profiling of diverse cancer cachexia models uncovers a multi-tissue metabolite-coordinated response associated with disease progression.
nature.com/articles/s42255-0…
Michel Kahi retweeted
Happy to share a new paper from the @SonenbergLab where we show that the ISR downstream effector ATF4 plays a role in mGluR-LTD
pnas.org/doi/10.1073/pnas.25…
Thank you to all the coauthors.
Michel Kahi retweeted
New! Online now: Modeling lipid homeostasis using stable isotope tracing and flux analysis dlvr.it/TR4Jj0
Michel Kahi retweeted
Delighted to share our latest study highlighting a critical role of the integrated stress response and ATF4 in promoting immune evasion via LCN2. By performing a focused in vivo CRISPR/Cas9 screen against ATF4 targets in collaboration with Francisco J. Sánchez-Rivera , we identify tumor cell derived LCN2 as the key mediator of ATF4-dependent immune suppression. In an amazing collaboration with Shohei Koide and John Kilian, we developed anti-LCN2 antibodies that showed single agent efficacy, increased T cell infiltration and tumor suppression in immune “cold” lung and pancreatic adenocarcinomas. Kudos to Jozef Bossowski and @RayPillaiMD who led this study and to the many collaborators who contributed including Sergei Koralov, Volkan Sayin, Diane Simeone @zervanto and Kwok Wong.
@Nature @Perlmutter_CC @nyugrossman
nature.com/articles/s41586-0…
Michel Kahi retweeted
DHODH turns cytosolic, yet cells keep growing dlvr.it/TR0jb9
Michel Kahi retweeted
#Throwback
CORRESPONDENCE | JP Pradère et al.
EMito-Metrix enables automated evaluation of mitochondrial morphology across species
nature.com/articles/s42255-0…























